Bulletin
Investor Alert

CymaBay Therapeutics Inc.

NAS: CBAY

GO
/marketstate/country/us

After Hours

/zigman2/quotes/201917619/composite

$

6.50

Change

-0.01 -0.15%

Volume

Volume 13,169

Sep 25, 2020, 7:32 p.m.

Quotes are delayed by 20 min

/zigman2/quotes/201917619/composite

Previous close

$ 6.36

$ 6.51

Change

+0.15 +2.36%

Day low

Day high

$6.28

$6.67

Open
Open: 6.33

52 week low

52 week high

$1.21

$7.09

Open

Market cap

$448.45M

Average volume

4.22M

P/E ratio

N/A

Rev. per Employee

N/A

EPS

-1.16

Dividend

N/A

Div yield

N/A

Ex dividend date

N/A

Compare:
Indexes
  • Dow(INDU) INDU
  • Nasdaq (COMP) COMP
  • S&P 500 (SPX) SPX
  • Global Dow (GDOW) GDOW
1d
5d
3m
6m
1y
3y
5y
/news/latest/company/us/cbay

MarketWatch News on CBAY

  1. CymaBay Therapeutics stock price target raised to $6.00 from $1.50 at B. Riley FBR

    7:47 a.m. May 13, 2020

    - Tomi Kilgore

  2. CymaBay Therapeutics upgraded to buy from neutral at B. Riley FBR

    7:46 a.m. May 13, 2020

    - Tomi Kilgore

  3. CymaBay Therapeutics upgraded to buy from hold at Stifel Nicolaus

    8:05 a.m. May 12, 2020

    - Tomi Kilgore

  4. CymaBay Therapeutics upgraded to outperform from market perform at Raymond James

    8:00 a.m. May 12, 2020

    - Tomi Kilgore

  5. 13D Filings

    9:31 p.m. March 20, 2020

    - Barron's Online

  6. CymaBay Therapeutics upgraded to outperform from perform at Oppenheimer

    7:10 a.m. March 13, 2020

    - Tomi Kilgore

  7. 4 Smaller, Cash-Rich Biotech Stocks That Could Be Havens

    9:06 p.m. March 6, 2020

    - Barron's Online

  8. CymaBay Therapeutics downgraded to market perform vs. strong buy at Raymond James

    9:48 a.m. Nov. 26, 2019

    - Ciara Linnane

  9. CymaBay Therapeutics shares down 77% premarket after resuming trade following halt

    9:33 a.m. Nov. 25, 2019

    - Ciara Linnane

  10. CymaBay shares fall 77% on halted trial

    9:34 a.m. Nov. 25, 2019

    - Jaimy Lee

  11. CymaBay Therapeutics started at buy with $14 stock price target at Stifel Nicolaus

    7:45 a.m. June 25, 2019

    - Tomi Kilgore

  12. CymaBay Therapeutics stock price target cut to $7 from $11 at B. Riley FBR

    12:15 p.m. June 17, 2019

    - Tomi Kilgore

  13. CymaBay Therapeutics upgraded to strong buy from market outperform at Raymond James

    7:27 a.m. June 12, 2019

    - Tomi Kilgore

  14. CymaBay Therapeutics started at neutral with $9 stock price target at B. Riley FBR

    10:08 a.m. Feb. 6, 2019

    - Tomi Kilgore

  15. CymaBay Therapeutics reiterated as buy at SunTrust Robinson Humphrey

    8:46 a.m. Dec. 31, 2018

    - Ciara Linnane

  16. 4 charts to watch as tech stocks rebound

    12:18 p.m. Feb. 14, 2018

    - Harry Boxer

  17. CymaBay Therapeutics started at outperform with $35 stock price target at Evercore ISI

    8:40 a.m. Feb. 13, 2018

    - Tomi Kilgore

  18. Loading more headlines...

Analyst Ratings

/news/nonmarketwatch/company/us/cbay

Other News on CBAY

  1. IPO Update: Metacrine Seeks $85 Million U.S. IPO

    2:58 p.m. Sept. 11, 2020

    - Seeking Alpha

  2. Oppenheimer Issues a Buy Rating on CymaBay Therapeutics (CBAY)

    11:05 p.m. Sept. 9, 2020

    - SmarterAnalyst

  3. CymaBay Therapeutics (CBAY) Received its Third Buy in a Row

    1:05 p.m. Sept. 9, 2020

    - SmarterAnalyst

  4. CymaBay Therapeutics (CBAY) Receives a Buy from B.Riley FBR

    12:35 p.m. Aug. 28, 2020

    - SmarterAnalyst

  5. Viking Therapeutics: Another Year In Review

    2:39 p.m. Aug. 13, 2020

    - Seeking Alpha

  6. CymaBay Therapeutics (CBAY) Gets a Buy Rating from B.Riley FBR

    9:35 a.m. Aug. 12, 2020

    - SmarterAnalyst

  7. ZI, NGL among premarket losers

    8:31 a.m. Aug. 11, 2020

    - Seeking Alpha

  8. CymaBay Therapeutics (CBAY) Received its Third Buy in a Row

    12:21 a.m. Aug. 11, 2020

    - SmarterAnalyst

  9. 10-Q: CYMABAY THERAPEUTICS, INC.

    4:06 p.m. Aug. 10, 2020

    - Edgar Online - (EDG = 10Q, 10K)

  10. CymaBay Therapeutics (CBAY) Gets a Buy Rating from B.Riley FBR

    12:50 a.m. Aug. 4, 2020

    - SmarterAnalyst

  11. US Indexes Close With Gains Monday

    4:36 p.m. Aug. 3, 2020

    - GuruFocus.com

  12. CymaBay Therapeutics (CBAY) Received its Third Buy in a Row

    12:50 p.m. Aug. 3, 2020

    - SmarterAnalyst

  13. RIOT, PBI, KODK and ALRM among midday movers

    12:45 p.m. Aug. 3, 2020

    - Seeking Alpha

  14. CymaBay Pulls Off Another Win With PBC Liver Disease Study

    11:08 a.m. Aug. 3, 2020

    - 247WallSt.com

  15. Loading more headlines...
/news/pressrelease/company/us/cbay

Press Releases on CBAY

  1. Quarterly Performance: $ABUS $IDEX $CBAY

    1:57 p.m. Aug. 6, 2020

    - The Market Signal

  2. Quarterly Performance: $ABUS $IDEX $CBAY

    10:13 a.m. Aug. 6, 2020

    - The Market Signal

  3. Loading more headlines...

Rates »

Link to MarketWatch's Slice.